Back to search

University of Peloponesse

Μοντέλο υποστήριξης αποφάσεων για τη χάραξη φαρμακευτικής πολιτικής και αξιολόγηση εφαρμοσμένων εργαλείων

Abstract

dc:description

This study introduces an innovative mathematical framework designed to quantify the societal cost associated with delays in the reimbursement and distribution of novel medicines. By integrating key public health and economic indicators—namely Years of Life Lost (YLL), Years of Potential Productive Life Lost (YPPLL), and Cost of Productivity Loss (CPL)—the proposed model provides a comprehensive assessment of the health, social, and economic consequences of delayed access to innovative therapies. The findings underscore the critical importance of timely pharmaceutical policy-making, particularly for medicines with high and well-documented clinical value. Delays in access not only reduce the therapeutic benefits available to patients but also amplify broader societal costs through increased premature mortality, diminished workforce participation, and heightened economic burden. The framework highlights that even relatively short delays may lead to disproportionately large losses in population health and productivity, emphasizing the need for differentiated policy approaches based on the clinical value of therapies. By adopting a broader societal perspective, the model supports a more balanced evaluation of pharmaceutical policy decisions, facilitating the trade-off between rapid patient access to innovation and the sustainability of healthcare expenditure. Furthermore, the framework functions as a decision-support tool for policymakers, enabling ex ante and ex post assessment of the societal and economic impact of reimbursement delays using data-driven methods. The study also highlights the pivotal role of data quality, completeness, and governance in ensuring reliable estimations of health and economic outcomes. Incomplete, inconsistent, or non-representative data may lead to biased assessments, suboptimal policy decisions, and inequities in access to healthcare. Overall, the proposed framework contributes to the advancement of value-based pharmaceutical policy by integratingreal-world data and mathematical modeling to maximize the societal benefits of medical innovation while safeguarding the long-term viability of healthcare systems.

Degree

thesis:*
Grantor dc:publisher
University of Peloponesse
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Theiakou, Foteini
  • Θειακού, Φωτεινή

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Theiakou, Foteini; Θειακού, Φωτεινή. Μοντέλο υποστήριξης αποφάσεων για τη χάραξη φαρμακευτικής πολιτικής και αξιολόγηση εφαρμοσμένων εργαλείων. University of Peloponesse, 2026. http://hdl.handle.net/10442/hedi/61164